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Abstract 
Hypertension is a major problem in the United States. It is critical to identify effective strategies 
to treat and manage hypertension. An experimental design was utilized to determine the 
effectiveness of home-based blood pressure monitoring (HBPM) in the management of pre-
hypertension, newly diagnosed, or uncontrolled hypertension. A randomized convenience sample 
of 20 adults was recruited into a control (n=9) and experimental (n=11) group. The translational 
care project was conducted over 60 days where participants measured their blood pressures as 
instructed for the intervention and control groups. An independent t-test was conducted to 
analyze the effectiveness of HBPM on the participants’ blood pressure, blood pressure 
knowledge, self-care, and medication adherence utilizing subsequent scales. There was a 
statistically insignificant increase in systolic blood pressure, but a statistically significant 
increase in diastolic blood pressure between the experimental and control groups at 60 days. 
There was no statistical significance in the improvement of HBPM adherence, knowledge, self-
care, or medication adherence between the two groups at 60 days. While there is limited 
statistical support for this translational research project, other resources support HBPM as an 
innovative program that has the potential to provide healthcare providers an avenue for more 
timely, effective, and individualized patient care. Literature demonstrates that improved blood 
pressure control has the potential to decrease the prevalence of co-morbid conditions and 
decrease health care costs. With an increase in successful studies legislation could be challenged 
to increase coverage and reimbursement cost for blood pressure monitors and more HBPM 
programs in practice. Continued research related to HBPM and patient adherence is necessary to 
improve patient access to affordable care and overall self-care outcomes. 
Keywords: hypertension, home, blood pressure, monitoring, self-care





Implementing a Home-Based Blood pressure Monitoring Program  
To Improve Hypertension Management 
Chapter I  
Introduction 
 According to the National Health and Nutrition Examination Survey (NHANES) (2011-
2012), approximately 70 million people in the United States (US) have high blood pressure, 
clinically known as hypertension (Nwankwo, 2014). Complications as a result of hypertension 
and rising health care costs make this an important issue to address. Best practices demonstrate 
that daily blood pressure monitoring in the home setting, also known as Home-Based Blood 
Pressure Monitoring (HBPM), increases patient awareness of the disease process and allows 
patients to monitor their blood pressure in their natural setting (Parati et al., 2010). Results from 
home blood pressure monitoring allows for providers to analyze home data trends and provide 
appropriate feedback. The purpose of this translational research project is to determine the 
effectiveness of home-based blood pressure monitoring in the management of those diagnosed 
with pre-hypertension, newly diagnosed, or uncontrolled hypertension. 
Problem 
 Currently, hypertension diagnosis and management is based on several blood pressure 
readings conducted in various clinical settings at random times of the day. However, a single 
blood pressure reading in the conventional office or emergency room setting does not reflect 
whether the patient is hypertensive or if hypertension is being managed properly. High blood 
pressures in the office setting could be related to stress and the white-coat phenomenon. White-
coat refers to a false elevation in blood pressure in the provider’s office, hence white-coat (Parati 
et al., 2010). Daily blood pressure monitoring in the home setting increases patient awareness of 





the disease process, allows patients to monitor their blood pressure in their normal setting, helps 
detect white-coat or masked hypertension, and provides several measurements where blood 
pressure trends can be evaluated (Parati et al., 2010). Results from daily monitoring allows for 
providers to analyze home data trends and provide appropriate feedback. Therefore, 
implementation of a home-based blood pressure monitoring program has the opportunity to 
improve hypertension management and encourage self-management practices among 
hypertensive patients.  
Background 
 The American Heart Association (AHA, 2016a) describes blood pressure as the force of 
the blood within the heart, which is measured by a fraction of two numbers. The systolic blood 
pressure (numerator) measures the pressure in the arteries when the heart contracts and the 
diastolic blood pressure (denominator) measure the relaxation phase of the heart when it refills 
with blood (AHA, 2016a). Blood pressure results are usually obtained using a 
sphygmomanometer in the upper arm above the elbow. Normal blood pressure is considered 
anything less than 120/80 and anything greater than this is considered pre-hypertensive or 
hypertensive. Pre-hypertension constitutes an increased blood pressure level between 121/81 and 
139/89 where providers may consider further evaluation. Hypertension is an elevated blood 
pressure, greater than 140/90, where the force of blood pushing against the vessels of the heart is 
too high and requires prompt evaluation and treatment (AHA, 2016b).  
 With the large prevalence of Americans having hypertension, the US experiences an 
health care spending cost of over $46 billion dollars annually for the management of 
hypertension and associated comorbidities (Nwankwo, 2014). According to the American Heart 
Association (AHA), uncontrolled hypertension results in end-organ damage, which includes 





heart disease, heart failure, stroke, and renal death (AHA, 2016b). In the US, hypertension and 
diabetes are the leading causes of kidney disease resulting in end-stage renal disease (ESRD) and 
death (CDC, 2014). In 2012, over $29 billion of the Medicare budget was used in the 
management of kidney disease and failure (CDC, 2015). Among African Americans, one of the 
leading causes of Chronic Kidney Disease (CKD) is uncontrolled hypertension with a prevalence 
rate of approximately 45% among men and women (Nwankwo, 2014). African Americans also 
have a 2-fold higher incidence of uncontrolled hypertension and an eight-time higher risk of 
stroke (Piper et al., 2015).  
 The CDC developed quality initiatives for the prevention, treatment and control of 
hypertension (CDC, 2015). With the substantial evidence of the prevalence of hypertension and 
its associated costs for comorbid conditions, it is imperative to implement evidence-based 
research strategies for improving hypertension management. A literature review demonstrated 
the potential for Home-based blood pressure monitoring (HBPM) to improve the care of those 
with hypertension. HBPM is the act of taking an individual’s blood pressure in the comforts of 
the patients’ home and recording results for later evaluation by the patients’ provider. The 
objective of this translational research project was to disseminate evidence-based care practices 
for blood pressure management through implementing home-based blood pressure monitoring 
into the health care setting.  
Terms and Definitions  
 Ambulatory blood pressure Monitoring (ABPM) is a diagnostic procedure where an 
automatic cuff is given to the patient from an outpatient lab source and measurements are taken 
every 15-20 minutes during the day and 20-30 minutes at night through a 24-hour period  
(Cohen, Huan, and Townsend, 2014).  





 Chronic Kidney or Renal Disease is a condition involving the decline of the kidney 
function, which normally cleans and filters the blood (CDC, 2014). In relation to hypertension it 
is important for blood pressures to remain stable to prevent further kidney damage.  
 Diabetes Mellitus is a condition where the blood’s sugar levels remain elevated for long 
periods of times (CDC, 2011). Due to the ability of this condition to cause further damage to 
multiple organs including the heart, it is important that blood pressures remain stable. 
 Electronic blood pressure Monitoring (EBPM) is similar to HBPM, but includes 
transmitting the blood pressure results electronically to the health care provider via email or into 
the patient’s electronic medical record (EMR) (Cohen, Huan, and Townsend, 2014).  
 Home-Based Blood pressure Monitoring (HBPM) is defined as the act of taking an 
individual’s blood pressure in the patient’s home twice daily (Cohen, Huan, and Townsend, 
2014). 
 Office blood pressure Monitoring (OBPM) occurs in the office setting where 
measurements are taken at the patients’ appointment for objective vital signs  (Cohen, Huan, and 
Townsend, 2014).  
Purpose  
 The purpose of the translational research project was to determine the effectiveness of 
home-based blood pressure monitoring in the management of pre-hypertension, newly 
diagnosed, or uncontrolled hypertension. Since uncontrolled hypertension is one of the leading 
causes of end-organ damage, which includes heart disease, stroke, and renal death predominantly 
in African Americans, the objective was to disseminate evidence-based care practices for blood 
pressure management into the health care setting. The primary investigator (PI) developed a 
home-based blood pressure monitoring program utilizing an educational program and the Omron 





sphygmomanometer, a blood pressure monitoring device. The Omron blood pressure monitor 
records and stores blood pressure results and downloads results to an Omron Wellness 
application ("10 Series Upper Arm Blood Pressure Monitor," 2016). Though this mobile 
application blood pressure results are transmitted to the health care provider via a secure email. 
The goal was to provide an easily adaptable implementation process for the home-based 
monitoring system in practice and to improve monitoring compliance and blood pressure results. 
This innovative technology has the potential to help health care providers deliver individualized 
patient care based on accurately reported blood pressure results. Improved blood pressure control 
has the potential to decrease complications of uncontrolled blood pressure and decrease health 
care costs. 
Aims and Clinical Questions 
There were three main aims for this translational research project:  
1. To reduce resting blood pressure to less than 140/90, in Diabetics (individuals with 
elevated blood sugars) and Renal disease (individuals with a decline kidney in kidney 
function) 130/80, or demonstrate a 5% reduction in blood pressure among men and 
women with primary hypertension. 
a. In adults’ age 18-60 years old with primary hypertension, what is the effect of 
a home-based blood pressure monitoring program compared to conventional 
outpatient blood pressure monitoring in the health care setting within 60 days? 
2. To increase adherence to home blood pressure monitoring among men and women 
with primary hypertension. 
a. Does HBPM in patients with primary hypertension increase adherence to 
home blood pressure monitoring?  





3. To increase adherence to hypertension lifestyle changes.  
a. Does HBPM in patients with primary hypertension increase adherence to self-
care lifestyle changes? 
4. To increase adherence to hypertension medication therapy.  
a. Does HBPM in patients with primary hypertension increase adherence to 
medication compliance? 
Opportunities and Challenges 
 Since uncontrolled hypertension is one of the leading causes of CKD in African 
Americans, the objective is to disseminate evidence-based care practices for blood pressure 
management into the primary care setting. Research demonstrates that home-based blood 
pressure monitoring can increase the diagnosis and management of hypertension as opposed to 
office blood pressure monitoring (Crabtree & Stuart-Shor, 2014). This translational research 
project provides a roadmap to implementing HBPM into practice. The PI developed a home-
based blood pressure monitoring program that facilitated a step-wise approach to tackling 
hypertension monitoring and management. The future goal is to have an interface system for 
every primary care or hypertension clinic. This would allow remote management of hypertension 
and increase productivity for other acute or chronic visits. HBPM has the potential to minimize 
follow-up visits related to blood pressure rechecks and allows the patient to conserve resources 
related to transportation or time off work. This innovative technology has the potential to health 
care providers deliver individualized patient care based on accurately reported blood pressure 
results (Young et al., 2015). Improved blood pressure control potentially decreases associated 
co-morbid conditions and thereby decreases health care expenditures and expenses (CDC, 2015). 
 The primary stakeholders for this project were the patients and patients’ families. Other 





stakeholders include health care providers, nurses, and medical assistants. There were no major 
financial burdens to incur with the implementation of HBPM to the health care clinics or 
patients. The PI enlisted funding through a “Go Fund Me” account, which solicited donations. 
Funding from the “Go Fund Me”, Carolyn M. Maynard Nursing Scholarship fund and Marjorie 
G. Prentice Graduate Research Scholarship provided blood pressure monitors to participants and 
covered the cost related to educational materials. However, the cost of monitors may become a 
challenge for practices without grant or governmental assistance. Training and education on the 
proper procedure for taking the blood pressure and the Omron Wellness application for the staff 
and patients was necessary. The PI conducted educational sessions demonstrating the appropriate 
frequency of blood pressure monitoring, proper body mechanics when taking blood pressure, and 
documentation with the Omron Wellness application. This could also commence a challenge, for 
this would require additional staffing or time dedicated to patient education and staff training that 
would deduct from regularly scheduled patient care. Most importantly, the patients must be fully 
invested in their own health and assume responsibility for adhering to the treatment plan.  





Chapter II  
Review of Literature and Synthesis 
 This chapter will review current literature regarding HBPM in relation to the 
management of hypertension. The chapter discusses the search criteria utilized to obtain 
literature and defines terms related to HBPM and blood pressure management. Lastly, a 
synthesis of the major themes identified and critical analysis of literature is detailed in this 
section.  
Search for Evidence 
 The investigation consisted of a search of research-based articles in CINHAL, 
MEDLINE, MEDLINE Plus Text, and PubMed published in 2010 or later. The search terms 
used were “home blood pressure monitoring” AND “hypertension” AND “African Americans” 
OR “Chronic Kidney Disease”. Some articles revealed alternate forms of HBPM. Therefore, 
alternate terms were searched including “ambulatory blood pressure monitoring,” “home-based 
blood pressure monitoring,” “self-blood pressure monitoring,” “office blood pressure 
monitoring,” and “electronic blood pressure monitoring.” Articles were eliminated based on the 
amount of relevance to HBPM in the management of hypertension and evidence strength. 23 
articles were reviewed and 12 were selected for the inclusion in this synthesis of research.  
Summary of Evidence 
 The literature reviewed consisted of literature reviews (4), randomized controlled trials 
(4), and case/cohort studies (3) that supported the use of either HBPM or ambulatory blood 
pressure monitoring (ABPM). The synthesis of literature revealed three major themes: 1) HBPM 
improves blood pressure control, 2) HBPM provides prognostic and diagnostic value of high 
blood pressure and decreases the progression of co-morbid conditions, including Chronic Kidney 





Disease (CKD), 3) SMBP or HBPM provided an equivocal measurement of blood pressure as 
compared to ABPM. The following provides a summary of the research evidence discovered in 
the literature review in support of the implementation of the translational research project. 
 The main theme discovered was that HBPM demonstrated a significant improvement in 
blood pressure management. McManus et al. (2010) reports a prospective-randomized control 
trial of 480 Caucasian patients that compared HBPM to traditional office based care. Results 
showed an average decrease of 30.5 mmHg in systolic blood pressure, which was statistically 
significant (p=0.002) (McManus et al., 2010). The same author conducted a similar randomized 
clinical trial to determine the effect of self-measured blood pressure monitoring (SMBP); results 
showed a 12-point reduction in systolic blood pressure after 12 months (McManus et al., 2014). 
The randomized control trial by Margolis et al. (2012) was a HBPM program that involved a 
pharmacist dosing and titrating antihypertensive medications based on blood pressure results 
received from a blood pressure telemonitoring system. In 228 patients from the telemonitoring 
intervention, an average reduction of 18 mmHg was noted in the systolic blood pressure 
(Margolis et al., 2012). Crabtree and Stuart-Shor (2014) developed an HBPM program in a 
community health center; results showed that among 50 patients, 60% experienced blood 
pressure improvement and 84% stated the program helped increase their knowledge and 
understanding of blood pressure management. In a case study of 46 CKD patients, White (2009) 
focused on increasing patient involvement in a HBPM program. The case study showed a 50% 
improvement in blood pressure management among CKD patients with hypertension (White, 
2009). A literature review of 52 prospective comparative studies on SMBP monitoring in adults 
with hypertension by Uhlig, Patel, Ip, Kitsios, and Balk (2013) provided supportive evidence of 





the use of SMBP alone or in combination with medication regimen improved blood pressure 
control compared to office setting monitoring. 
 The second theme identified was that ABPM and HBPM alike provided prognostic and 
diagnostic value in high blood pressure. Researchers were able to diagnose masked or white-coat 
hypertension, as well as predict end-organ damage from uncontrolled hypertension with HBPM. 
Another prospective cohort studied the prognostic ability of ABPM in 436 CKD patients 
(Minutolo et al., 2011). After approximately four years of tracking and trending this group of 
patients, 86 of the patients progressed to ESRD (20%), 63 experienced non-fatal cardiovascular 
events (14%) and 52 succumbed to cardiovascular death (12%) (Minutolo et al., 2011). This 
study demonstrated that nighttime blood pressure with ABPM proved to be an accurate 
prediction of renal and cardiovascular risk (Minutolo et al., 2011). A similar literature review by 
Cohen, Huan, and Townsend (2014) showed that HBPM and ABPM were useful instruments in 
the diagnosis of hypertension. Stergiou, Kollias, Zeniodi, Karpettas, and Ntineri (2014) 
conducted a literature review revealing the advantages and limitations of HBPM in clinical 
practice; the evidence exhibited that HBPM has prognostic and diagnostic ability, and improved 
medication adherence. Piper et al (2015) also conducted a literature review that examined the 
benefits of ABPM for diagnostic and predictive value; a review of 27 articles showed strong 
evidence that ABPM is more accurate in the diagnosis of hypertension.  
 Lastly, evidence demonstrated that HBPM provided an equivocal measurement of blood 
pressure as compared to ABPM, a more expensive diagnostic monitoring technique (McGowan 
& Padfield, 2010). McGowan and Padfield (2010) conducted a comparative study among 87 
participants whom had recently undergone ABPM. The researchers provided blood pressure 
monitors and education to the individuals and compared SMBP to ABPM. Results demonstrated 





that there was no difference in blood pressure results obtained via ABPM versus SMBP 
(McGowan & Padfield, 2010). Stergiou, et al. (2014) not only provided diagnostic value of 
HBPM as previously stated, but research also exhibited that HBPM is reflective and consistent 
with ABPM. This summary of evidence provides a foreground in developing a framework to 
disseminate a home-based blood pressure monitoring program in the care of patients with pre-
hypertension, uncontrolled hypertension or newly diagnosed hypertension. 
Summary of Expert Evidence 
The U.S. Preventive Services Task Force (USPSTF, 2016) published the final 
recommendation for the utilization of ambulatory blood pressure monitoring (ABPM) in the 
screening and diagnosis of hypertension, titled “Final Recommendation Statement: High Blood 
Pressure in Adults: Screening”. The study investigated how well home and ambulatory blood 
pressure monitoring methods predict cardiovascular events compared with clinic-based blood 
pressure measurement methods. The USPTF (2016) recommends that ambulatory blood pressure 
monitoring and home blood pressure monitoring be utilized prior to diagnosing hypertension and 
beginning treatment. The USPTF (2016) also states that “good-quality” evidence demonstrates 
that HBPM is equally as effective as ABPM in the diagnosis and management of hypertension. 
Critical Analysis of Current Evidence  
The literature reviewed for the project consisted of literature reviews (Cohen et al., 2014; 
Parati et al., 2010; Piper et al., 2015; Uhlig et al., 2013), randomized controlled trials (Margolis 
et al., 2012; McManus et al., 2010; McManus et al., 2014; Stergiou, et al., 2014), and cohort 
studies (Crabtree & Stuart-Shor, 2014; McGowan & Padfield, 2010; Minutolo et al., 2011; 
White, 2009) that supported the use of either HBPM or ambulatory blood pressure monitoring 
(ABPM). Literature reviews and randomized control trials are considered to be the highest 





quality of research and made up a majority of this literature review. A critical analysis of the 
research literature was conducted utilizing Melnyk and Fineout-Overholt (2011) critical appraisal 
of quantitative research to assess validity, reliability and applicability. 
Literature Reviews  
A narrative review of blood pressure monitoring in CKD patients conducted by Cohen et 
al. (2014) discusses the results and findings of several research articles. The review describes 
only a few of the studies locations, sample sizes, length of follow-up and outcomes. The results 
discuss the benefit of HBPM in the use of blood pressure management in patients with CKD and 
predicting end-organ damage. However, this particular literature review was not systematic or 
methodological in its approach, and lacks an intervention effect or any statistical significance.  
Cohen et al. (2014) remains applicable to the translational research project at hand by reviewing 
recent literature that provides guidance on proper blood pressure monitors for HBPM, discussing 
the importance of ruling out white-coat hypertension and masked hypertension to diagnose true 
high blood pressure, and providing a foreground for interfacing HBPM into electronic health 
records. 
Parati et al. (2010) another narrative review provides a summary of guidelines necessary 
for HBPM. While this literature review is not methodological in manner, it does provide 
supportive national guidelines for the implementation of HBPM into practice. A large 
component of applicability resides in this review, for it provides information on the advantages 
and shortcomings to HBPM, validated blood pressure monitors, optimal monitoring schedules, 
HBPM analysis techniques, and indications for HBPM (Parati et al., 2010). While Parati et al. 
(2010) provides a strong basis of clinical guideline support, it was important to note that there 
was some conflict of interest with the authors’ relationships with some medical equipment 






Piper et al. (2014) established a literature review of 27 research articles to demonstrate 
that elevated OBPM should be confirmed by ABPM to avoid over or under diagnosis of 
hypertension and improve the diagnostic accuracy of office blood pressure measurement for 
screening. This literature review was systematic and methodological in nature by detailing the 
populations, sample sizes, and outcomes. Piper et al. (2014) identified and incorporated solely 
randomized control trials and graded the literature based on quality. The author also summarized 
the review in table format that made it particularly simple to evaluate the hazard ratios and 
positive predictive values of the literature review with the displayed treatment effects and 95% 
confidence intervals (CI). With HBPM being a more cost-effective way of blood pressure 
monitoring outside the office similar to ABPM, this review provides applicability to the 
translational research project in supporting HBPM for the diagnosis and treatment of 
hypertension. 
A systematic review and meta-analysis was conducted by Uhlig et al. (2013) to describe 
the efficacy of self-measured blood pressure monitoring (SMBP), also known as HBPM. As 
given its subtitle, the literature review was both systematic and methodological in the processes 
of data search, extraction and synthesis or research as instituted by the Agency for Healthcare 
Research and Quality (AHRQ). The author only sequestered randomized control trials (RCTs) 
and provided each published work’s locations, sample sizes, interventions and outcomes. The 
literature review synthesized the results of 52 studies detailing the relative risk (RR) and 
statistical significance of each study (Uhlig et al., 2013). Uhlig’s et al. (2013) systematic review 
and meta-analysis provided significant support for the translational research project in that the 
review corresponded SMBP to notably improve blood pressure management over a six-month 





period, especially in the presence of clinical support agents. 
Randomized Control Trials  
Margolis et al. (2013) is a RCT demonstrating that home-based blood pressure 
telemonitoring and pharmacist-led antihypertensive management, improved blood pressure 
(SBP) over a 12 month period compared to OBPM and management. The study consisted of the 
random assignment of 450 participants into a treatment intervention and control group with 
explicit inclusion and exclusion criteria; however, the facilitators and stakeholders were not blind 
to the group assignments. Statistical methods were utilized to obtain an effect size for the 
prospective sample and authors increased participant recruitment by the calculated odds of 
patients completing the study over the predetermined length of time. The interventions utilized 
validated blood pressure telemonitors and a one-on-one meeting with a Pharm-D (Margolis et al., 
2013). The study demonstrated an average difference in SBP and DBP of -10.7 mmHg and -6 
mmHg at six months from the experimental group to the control group with a CI of 95% (-14.3 - 
-7.3; -8.6 - -3.4) (Margolis et al., 2013). The results of this study are clinically relevant and 
imperative to the translational research project of HBPM in hypertension management.  
Both McManus et al. (2010) and McManus et al. (2014) are un-blinded RCTs that 
measure the effectiveness of SMBP and self-titration of antihypertensive therapy versus usual 
care. McManus et al. (2010) simply studied SMBP among primary care practices (n= 480) and 
McManus et al. (2014) studied the intervention among those with increased cardiovascular risks 
(n=522). Despite the fact that neither studies provided effect size data, both studies’ participants 
were recruited and randomly assigned to the treatment and control group with reasons given for 
those subjects who did not complete the study in a flow-chart figured in each manuscript. The 
intervention groups received blood pressure monitors that were verified and reliable and 





developed self-titration algorithms with their nationally certified primary care providers 
(McManus et al., 2010; McManus et al., 2014). In the initial McManus et al. (2010) study there 
was a -12.9 mmHg (95% CI 10.4-15.5) decrease in SBP among the experimental group versus 
the control groups -9.2 mmHg (95% CI 6.7-11.8). In the study involving at-risk cardiovascular 
participants, SBP/DBP was -9.2 mmHg/-3.4 mmHg lower in the intervention group versus the 
control group respectively (95% CI 5.7-12.7)/(95% CI 1.8-5.0) (McManus et al., 2014). The 
findings of these studies help support the importance of instituting HBPM into practice. 
The last RCT was conducted in a hospital outpatient clinic to compare HBPM to ABPM 
management (Stergiou, et al., 2014). Participants were blindly randomized into a treatment and 
control group based on a statistically identified effect size of 122 participants (Stergiou, et al., 
2014). One strength of the study is the strategic placement of a flow diagram outlining the 
recruitment phase of participants and those whom withdrawn from the study, which supports the 
use of a flow diagram for this translational research project. The use of this flow diagram 
motivated the researcher to construct a similar diagram for this translational research project. The 
treatment group received home blood pressure monitors and antihypertensive medications were 
titrated based on HBPM results, while the control group utilized either OBPM or ABPM and had 
medications titrated based on the clinic or ABPM results (Stergiou, et al., 2014). End-organ 
diagnostic testing and blood pressure results were assessed pre and post-intervention to 
determine the reliability of HBPM versus ABPM. Stergiou, et al. (2014) provides a visual of the 
relationships between the various treatment methods with elements describing the standard error 
and confidence intervals. The study demonstrated that HBPM is comparable to ABPM and clinic 
management showing no statistical difference between treatments. 





Cohort Studies  
Crabtree and Stuart-Shor (2014) is a cohort study to implement HBPM into practice at a 
health care facility. Participants were recruited from a single primary care office whom were 
diagnosed with a high blood pressure of >140/90 mmHg. Participants were given validated blood 
pressure monitors and education on proper blood pressure monitoring and treatment. Crabtree 
and Stuart-Shor (2014) indicated a 60% improvement in blood pressure control (BP<130/80), of 
which, 84% of patients felt that the HBPM program helped them understand and manage their 
blood pressure, enhanced their doctor visits, and added value to their care. Although blood 
pressure management improved with HBPM, there was no magnitude of relationship indicators, 
p-values or CIs documented in the results. However, there was a strong applicability and 
correlation to the presented translational research project in that the study demonstrates Home-
based blood pressure monitoring is valuable in the improvement of hypertension knowledge and 
disease management adherence among patients.  
 McGowan and Padfield (2010) conducted a comparative cohort study among 87 
participants whom had recently undergone ABPM. The researchers provided validated blood 
pressure monitors and education to the individuals and compared SMBP to ABPM. Results 
demonstrated that there was no difference in blood pressure results obtained via ABPM versus 
SMBP (McGowan & Padfield, 2010). HBPM matched ABPM results in 87% of the individuals. 
Statistical analysis demonstrated a correlation and repeatability coefficient of 0.72 (CI 95%, 
0.57-0.82) and 5.2 (CI 95%, 4.1-6.2) respectively for SBP (McGowan & Padfield, 2010). For the 
DBP the correlation and repeatability coefficient was 0.89 (CI 95%, 4.1-6.2) and 5 (CI 95%, 4.1-
6.2) respectively (McGowan & Padfield, 2010). Subjectivity of the study was limited, however, 
no adjustments were made to rule out confounding variables. The applicability of the study in 





HBPM provides reassurance that HBPM can be substituted for ABPM in the clinical setting and 
provides accurate results in the care of hypertensive patients.  
Specifically in chronic kidney disease, Minutolo et al. (2011) a cohort study, determined 
that nighttime ABPM demonstrated precise prediction of renal and cardiovascular risk (n=436). 
ABPM was compared to OBPM for predicting the time to end-stage renal death or 
cardiovascular complications. Elevated nighttime blood pressure (>137 mmHg SBP) during 
ABPM is associated with increased risk of end stage organ death unlike OBPM (Minutolo et al., 
2011). The magnitude of relationship indicators, p-values and CIs are documented in the results 
providing reliability to the results. With ABMP being proven to be comparable to HBPM, 
HBPM holds similar predictive and prognostic value. While the purpose of the translational 
research project is to demonstrate that HBPM improves the management of hypertension, the 
applicability in this study lies in the support of HBPM and its role in preventing the progression 
of chronic diseases. 
 White (2009), cohort study conducted at a nephrology practice, recruited 46 CKD 
patients with hypertension to perform HBPM. Participants were selected by the clinical staff and 
provided with validated blood pressure monitors. Participants submitted HBPM results on a 
monthly basis and results demonstrated approximately a 50% improvement in hypertension over 
a six-month period. There were subjective statements by the researcher noted in the study report 
that could introduce bias to the results. The data analysis did not adjust for risk factors or 
confounding variables such as race, age, and gender. Unfortunately, the White (2009) study is 
statistically frail with insufficient statistical data and data analysis to support the study of HBPM. 
Yet, the results of the study help provide important educational and implementation techniques 
for the HBPM translational research project. 





Limitations of Current Evidence 
 This literature synthesis provides an abundance of research on the topic of HBPM and 
has supported the use of various types of self-monitoring techniques for the diagnosis, 
management and prognosis of blood pressure control (Cohen et al., 2014; Crabtree & Stuart, 
2014; McManus et al., 2014; McManus et al., 2010; Piper et al., 2015; Minutolo et al., 2011; 
Margolis et al., 2012; Stergiou et al., 2014; Uhlig et al., 2013; White, 2009). Palatini and Frick 
(2012) discuss limitations to the implementation of HBPM into practice to include lack of 
methodological implementation, utilization of invalidated blood pressure monitoring equipment, 
result inaccuracy related to misreporting, and inadequate staff and patient education. The gap in 
the literature was identified with only a few studies having been conducted on the use of HBPM 
with the influence of hypertension education on the improvement of hypertension management 
and medication adherence.  
 While national organizations such as the CDC (2015) and USPSTF (2016) support and 
provide guidance for the use of HBPM or SBPM alike, there is limited research that 
demonstrates that HBPM is effective and worth the efforts of instituting into practice. Some 
literature lacks critical quantitative evidence and strength. Of the literature reviewed, common 
research limitations were related to the introduction of bias with un-blinded RCTs, inadequate 
participant recruitment and under-represented patient samples. Other limitations discovered in 
the literature review included: lack of evaluation of confounding variables, inconsistent medical 
management and treatment of hypertension, limited study length and follow-up, research 
generalizability and reproducibility in multiple settings, and no cost analyses were conducted. 
The translational research project addressed several of these factors in effectively implementing 
HBPM into practice. 





Strengths of Current Evidence 
 All the studies examined in this literature review were applicable to the study of HBPM 
in the management or improvement of hypertension. A majority of the studies discovered in the 
appraisal of literature were systematic reviews or randomized control trials, which are 
methodologies that more accurately exemplify the entire population. Several studies like 
McManus et al. (2010) and McManus et al. (2014) contained large sample sizes with statistically 
supportive results demonstrating that HBPM is effective in blood pressure control and decreases 
the risk of end-organ damage. Several studies also provided evidence demonstrating that HBPM 
is a more cost effective and reliable substitution for OBPM and ABPM (McGowan & Padfield, 
2010; Minutolo et al., 2011; Piper et al., 2015; Stergiou, et al., 2014).  Other research studies 
provide statistically significant evidence representing that HBPM provides prognostic and 
diagnostic value in high blood pressure (Cohen et al., 2014; McManus et al., 2010; McManus et 
al., 2014; Minutolo et al., 2011; Piper et al., 2015; Stergiou, et al., 2014). The synthesis of 
research provides a framework of support implicating HBPM as a potential factor in the 
management of hypertension. 
Apply the Evidence 
Given the prevalence of cardiovascular disease, kidney disease, and increased health care 
costs; it is beneficial to explore HBPM use in the primary care setting where the initial diagnosis 
and management of hypertension most often occurs. Utilization of HBPM should be initiated in 
the primary care setting to screen, diagnose and manage hypertension on a continuous basis. 
Evidence demonstrates that it is imperative to create and apply a methodological approach to 
HBPM as to successfully implement in practice. An important step in the methodology is to 
ensure patient and staff are properly educated in accurate HBPM procedures. Another important 





concept in HBPM is the need of an interface or software system similar to the pharmacist-led 
study due to the fact that electronic results improve evaluation, accuracy and efficiency of blood 
pressure outcomes (Margolis et al., 2013). Further investigation is necessary to determine a 
systematic way to effectively implement HBPM into practice.  
Theoretical Framework 
Translational/Change Theory 
 “Translating Evidence into Practice: A model of large-scale knowledge translation” by 
Pronovost, Berenholtz, and Needham (2008) introduces a model that enables evidence-based 
research to be implemented into practice. This theory provides an organized way to implement 
home-based blood pressure monitoring for patients with hypertension. The Translating Evidence 
into Practice theory is aimed at large-scale research projects and includes four phases: 
summarize evidence for improving a specific outcome, identify local barriers of implementation, 
identify outcomes of the implementation and performance measures, and finally ensure all 
patients reliably receive the intervention (Dudley-Brown, White, & Ebooks, 2012). The change 
theory orchestrates the synthesis of research to translate HBPM into practice. The plan is to 
utilize evidence-based practice to engage and educate staff on the importance of monitoring 
blood pressure outside the primary care clinic on a consistent basis. The PI will implement a 
program that records electronic home blood pressure readings and facilitate the electronic 
submission of those results. To evaluate the study, a baseline comparison of blood pressures 
prior to the intervention and blood pressures post intervention over an eight-week period will be 
conducted. 





Hill-Levine Conceptual Model 
 According to Young et al. (2015), medication non-adherence (70%) was the most 
common cause of uncontrolled hypertension in low income African Americans. According to the 
survey, causes of medication non-adherence included: expensive medications, prescription side 
effects, forgetfulness, no noted blood pressure improvement, lack of access to a physician, lack 
of transportation, and high pill frequency. Since adherence is the most common issue for 
uncontrolled hypertension in African Americans, it is important to consider the Hill-Levine 
Conceptual model (1999) for improving patient adherence to the individual’s treatment plan 
(Figure 1) (Hill et al., 1999). Greer and Ostwald (2015) adapted the Hill-Levine’s Conceptual 
Model to provide an educational hypertension program sensitive to the cultural attitudes and 
beliefs of African American women. This conceptual model was utilized in the formation of the 
educational phase of the HBPM program implemented in this translational research project. 
 The conceptual model (Figure 1) identifies predisposing, enabling, and reinforcing 
factors as the foundation of the framework when building a culturally competent educational 
program. This diagram represents the framework of the Hill-Levine Conceptual Model and the 
steps it takes to improve medical adherence and achieve controlled hypertension. This 
foundation helps the PI address current knowledge and positive or negative beliefs about 
hypertension (predisposing factors). The conceptual model ensures the individual is provided 
with the resources necessary to succeed in the program by assessing and providing health 
behavioral skills (enabling factors). Lastly, the model incorporates the subject’s environment and 
support systems for motivational help and guidance (reinforcing factors).  
  








Figure 1: Hill-Levine’s Conceptual Model for Hypertension Management Adherence.  
 
 With these supportive factors the individual is provided with the recommendations for 
successful program completion resulting in positive health outcomes. In this case it would be 
controlled blood pressure and prevention of end-organ damage.  This is a culturally effective 
model, because it addresses the individuals’ issues and helps to reshape the person’s beliefs 
while providing social support from their own environment. Greer and Ostwald (2015) study of a 
culturally sensitive high blood pressure educational program among African American women 
demonstrated a statistically significant (p=.006) decrease in blood pressure over six months 
without any loss of participants, but the association between blood pressure and education were 
not statistically significant (p>.05). While this theoretical framework focuses on the behaviors of 
African American women, it provides practices that can benefit various cultures and individuals. 
Nonetheless, the theoretical framework was utilized to formulate the educational platform for the 





























The translational research project is a pre-test and post-test clinical trial of the 
effectiveness of HBPM. Consent of the Georgia College & State University Institutional Review 
Board (IRB) was obtained prior to beginning the recruitment of participants for this study. Consent 
and site approval was obtained from a primary care non-profit community clinic in rural North 
Georgia and a medical practice in suburban Central Georgia to implement study.  
Sample 
A convenience sample of participants 18 to 60 years old with pre-hypertension, newly 
diagnosed or uncontrolled hypertension was identified for the project. The age group is limited to 
18 to 60 based on the JNC VIII guidelines. According to the JNC VIII recommendations, elderly 
persons greater than 60 years old are given a higher threshold of blood pressure (150/90) (Abel et 
al., 2015). Physicians and practitioners from the two practices identified potential participants 
and provided them with unmarked folders. The folders contained the proposed project with 
HBPM education and consent forms for subjects to sign. Each informed consent was labeled 
with an identification number, but however concealed until participant opened and signed 
consent. The subjects were asked to read contents, sign informed consent, and submit consent 
forms to the clinic manager. The researcher retrieved consents from clinic manager and verbally 
confirmed consent with participants. The even numbered participants were a part of the 
experimental group and the odd numbered participants a part of the control group.  
Inclusion Criteria. The study sample included adult patients, male and female, 18 to 60 
years old with pre-hypertension (>130/80), newly diagnosed or uncontrolled essential 
hypertension (>140/90). The participants must have a pre-hypertension or hypertension diagnosis 





and be under the care of a physician for management. Each subject must be proficient in English 
or have a professional interpreter, have access to email and Internet or be able to travel to the 
clinic to submit results on a monthly basis. Lastly, participants must be physically capable of 
taking their own blood pressure twice a day or have a family member willing to participate. 
Exclusion Criteria. Subjects less than 18 years old or greater than 60 years old, 
pregnant, blood pressure greater than 200/100, terminal disease, dementia, or hypertension not 
managed by a physician. 
Variables 
 Descriptive data was obtained from medical records and a demographic survey 
(Appendix B). Descriptive variables defined in the study sample included gender, age, ethnicity, 
quantity of blood pressure medications prescribed (QoBPM), weight, height, Body Mass Index 
(BMI), tobacco use, pre-study HBPM use (PHU), past medical history (PMH), socio-economic 
factors (SEF). Outcomes variables include Systolic Blood pressure (SBP), Diastolic Blood 
pressure (DBP), high blood pressure knowledge scale (HBPKS), high blood pressure self-care 
scale (HBPSCS), and Morisky’s Medication Adherence Scale (MMAS-8).  
Project Phases 
The translational care project was conducted over eight-weeks and was divided into three 
phases: Educational Phase, Monitoring Phase, and Evaluation Phase. The healthcare providers 
referred patients with pre-hypertension, newly diagnosed or uncontrolled hypertension to 
participate in the project and given project information with informed consent. Once participants 
signed and submitted informed consent, the PI contacted participants to schedule educational 
sessions. Even numbered participants were a part of the experimental group and received blood 
pressure monitors with their educational session, whereas the odd numbered participants were a 





part of the control group and received educational session only. Educational courses were 
scheduled weekly on Tuesday’s from 5-7pm. Due to time constraints participants were scheduled 
for education in small groups immediately upon enrollment. Due to low participation, an 
additional practice site was added under the same guidelines as the initial practice site. 
Phase 1: Staff Education. Education was provided to the clinical staff of each facility to 
include: proper measurement techniques, monitoring home readings, and providing timely advice 
for medication titration and lifestyle changes from the Eighth Joint National Committee (JNC 
VIII) (James et al., 2014). The JNC VIII Algorithm was provided to physicians and providers as 
a standard guide to follow in the treatment of hypertension (Figure 2). 
  







Figure 2: JNC VIII Medication and lifestyle change algorithm (James et al., 2014).  
 
Phase 1: Participant Education. Participants recruited were assigned to their 
educational course based on their assigned identification number. The experimental group was 
provided with the same blood pressure monitors to minimize variance. Both groups received the 
same education regarding: definition of hypertension, importance of blood pressure management, 
proper measurement techniques, frequency of blood pressure monitoring, and blood pressure 
management protocol. Patient and staff educational materials included:  
Agency for Healthcare Research and Quality’s (AHRQ) Measuring Your Blood pressure at 






JNC 8 Hypertension Guideline Algorithm  
Lifestyle  changes: 
• Smoking Cessation 
• Control blood glucose and lipids  
• Diet 
9Eat healthy (i.e., DASH diet) 
9Moderate alcohol consumption  
9Reduce sodium intake to no 
more than 2,400 mg/day 
• Physical activity 
9Moderate-to-vigorous activity 
3-4 days a week averaging 40 
min per session. 
Adult aged ≥ 18 years with HTN 
Implement lifestyle modifications 
Set BP goal, initiate BP-lowering medication based on algorithm 
General Population 
(no diabetes or CKD) Diabetes or CKD present 
Age  ≥ 60 years Age  < 60 years All Ages 
Diabetes present 
No CKD 
All Ages and Races 












Initiate thiazide or CCB, 
alone or combo 
Initiate ACEI or ARB, 
alone or combo 
w/another class 
Reinforce lifestyle and adherence 
 Titrate medications to maximum doses or consider adding another medication  (ACEI, ARB, CCB, Thiazide) 
At blood pressure goal? 
Reinforce lifestyle and adherence 
Add a medication class not already selected (i.e. beta blocker, aldosterone antagonist, others) and titrate 
above medications to max (see back of card) 
Initiate thiazide, ACEI, ARB, 
or CCB, alone or in combo 
Reinforce lifestyle and adherence 
Titrate meds to maximum doses, add another med and/or refer to hypertension specialist 
Yes 
Continue tx and monitoring 
Initial Drugs of Choice for Hypertension 
• ACE inhibitor (ACEI) 
• Angiotensin receptor blocker (ARB) 
• Thiazide diuretic  
• Calcium channel blocker (CCB) 
At blood pressure goal? 
Strategy Description 
A Start one drug, titrate to maximum 
dose, and then add a second drug.  
B Start one drug, then add a second 




Begin 2 drugs at same time, as 
separate pills or combination pill. 
Initial combination therapy is 
recommended if BP is greater than 
20/10mm Hg above goal 
At blood pressure goal? 
Reference: James PA, Ortiz E, et al. 2014 evidence-based guideline for the management 
of high blood pressure in adults: (JNC8). JAMA. 2014 Feb 5;311(5):507-20  
Card developed by Cole Glenn, Pharm.D. & James L Taylor, Pharm.D. 





• American Heart Association’s (AHA, 2012) How to Monitor and Record Your Blood 
pressure; 
• AHA’s (2012) Instructional Video: Monitoring Blood pressure at Home.  
All tools utilized for education were created and supported by the CDC (2014) and are available 
free of charge on the CDC’s website “Self-Measured Blood pressure Monitoring Action Steps 
for Clinicians.” A pre-education baseline test was conducted to assess participants’ blood 
pressure knowledge and self-care abilities utilizing Peters and Templin (2008) Blood pressure 
Knowledge Scale and Blood pressure Self-Care Scale.  
All participants were provided with a Flagging system using the American Heart 
Association’s hypertension categories will be provided to participants to assure patients are 












mm Hg (upper #)   
Diastolic 
mm Hg (lower #) 
Normal less than 120 and less than 80 
Prehypertension 120 – 139 or 80 – 89 
High Blood pressure 
(Hypertension) Stage 1 140 – 159 or 90 – 99 
High Blood pressure 
(Hypertension) Stage 2 160 or higher or 100 or higher 
Hypertensive Crisis 
(Emergency care needed) Higher than 180 or Higher than 110 
Figure 3: Flagging System (AHA, 2016a).  
 
1. Green * (Normal)- Great job, your blood pressure is normal. Keep monitoring your bp twice daily. 
2. Yellow (Pre-Hypertension)- Your blood pressure is slightly elevated. Did you take your bp medications, 
have a high sodium meal, are you stressed? Keep monitoring your bp twice daily and taking medications as 
prescribed. 
3. Orange (Stage 1)- Your blood pressure is elevated. Did you take your bp medications, have a high sodium 
meal, are you stressed? Your provider may need to change your blood pressure medication. Keep 
monitoring your bp twice daily and taking medications as prescribed. 
4. Red (Stage 2)- Your blood pressure is very elevated. You should call your provider to schedule an 
appointment or discuss your bp medication regimen. Keep monitoring your bp twice daily. 
5. Red (Hypertensive Crisis)- Caution, CALL 911 
*if your pressure is <100/50, please notify your physician. If you begin to experience lightheadedness or dizziness 
please go to your nearest emergency department or call 911. 
 
Phase 2: Monitoring. After the educational phase patients were given the tools needed to 
monitor their blood pressures at home twice daily at 12 hours a part. The experimental group was 
expected to submit results to researcher for review monthly. The results were able to interface 
into Omron’s Wellness App, a HIPAA approved health information technology program 
accessible to those provided with the Omron blood pressure monitor. The Participants’ pre 
HBPM implementation blood pressure results were compared to post HBPM results to determine 
effectiveness of HBPM program. The PI was available in the clinic once a week and via phone 
for troubleshooting needs and for those without access to Internet or email. If participants were 





unable to submit results via email or during PIs available hours at the clinic, individuals were 
contacted to schedule a time to retrieve records. 
The control group received the same education as the experimental group, but did not 
receive blood pressure monitors. Participants among the control group were encouraged to obtain 
a home monitor and monitor home results with a blood pressure results handout to write in 
results twice daily. Blood pressure results were submitted to their health care provider during 
follow-up and the researcher reviewed the results in the EHR.  
Instruments 
Demographic Data 
The socio-demographics of the study sample were examined utilizing a demographic 
survey constructed by the researcher (Appendix A). The demographic information that was 
collected on the participants included: gender, age, ethnicity, quantity of blood pressure 
medications prescribed, weight, height, Body Mass Index (BMI), tobacco use, pre-study HBPM 
use, past medical history, socio-economic factors (education, marital status, employment status, 
household income and health insurance status). This information was used to describe the sample 
and for later data analysis. 
Blood Pressure Monitor 
Omron medical equipment has a reputation of providing quality medical grade 
equipment. The Omron BP786 monitor was tested and passed according to the protocols of The 
Association for the Advancement of Medical Instruments (AAMI) and the European Society of 
Hypertension (ESH) ("10 Series Upper Arm Blood Pressure Monitor," 2016). The Omron 10 
Series has the ability to take three consecutive blood pressure readings over ten minutes, and 
averages the results for an accurate and reliable reading. The blood pressure monitor features an 





“easy wrap ComFit Cuff, extra large display, and is able to save 200 readings” ("10 Series Upper 
Arm Blood Pressure Monitor," 2016, p. 1). The Omron BP786 is a sphygmomanometer model 
that is capable of transmitting data to the Omron Wellness application. Participants are then able 
to submit results via email through the application and to the patient's provider via a HIPAA 
approved information system. This eliminates the tediousness of writing and need for patients to 
keep a written log, which helps prevent the misinterpretation of results due to poor writing 
legibility or lack of memorization. The monitor is able to store results by keeping an electronic 
record of accurate blood pressure results that can be easily accessed and reviewed. This will 
allow the practitioner to be able to utilize supporting data to institute the best intervention 
necessary for treatment of the patient’s blood pressure. Topouchian et al. (2014) documents the 
validity of the Omron BP786 demonstrating less than 5 mmHg differences in SBP and DBP 
results based on the AAMI’s and ESH’s protocol. 
Knowledge and Self-care Scale 
Peters and Templin (2008) developed the Blood Pressure Knowledge (KS) and Self-Care 
(SC) scales utilizing the self-care deficit nursing theory by Orem (Appendix B). The scales were 
utilized in this translational research project to measure participants’ knowledge and self-care 
practices pre-education and post-HBPM intervention. This instrument helps measure the 
effectiveness of the phase one participant educational session to determine if hypertension 
lifestyle (low fat and salt diet, diet high in fruits and vegetables, daily 30-min physical activity, 
minimal stress, healthy weight, minimal alcohol and tobacco use, doctor follow-up, and 
medication adherence) changes had improved.. The Blood Pressure Knowledge Scale and the 
Blood pressure Self-Care Scale were 11 and 10-item questionnaires respectively (Peters & 
Templin, 2008). The Knowledge Scale assesses the comprehension and belief that particular 





behaviors improve blood pressure results and the Self-care Scale assesses how often the 
participants perform the specific behaviors (Peters & Templin, 2008). The behaviors analyzed 
included: maintaining a healthy diet, increased physical activity, stress management, weight 
management, avoiding alcohol or tobacco use, doctor follow-up and medication adherence. The 
scales utilized a seven-point bipolar scale from one to seven, measuring from “strongly disagree” 
to “strongly agree” for the knowledge scale and “never” to “always” for the self-care scale 
(Peters & Templin, 2008) (Appendix C). Some of the items are reverse coded with a total scale 
range from 11 to 77 for the Knowledge scale and 9 to 70 for the Self-Care scale (Peters & 
Templin, 2008).  The scales are valid and reliable demonstrating a Cronbach’s alpha of 0.85 
(KS) and 0.7 (SC) (Peters & Templin, 2008). The authors gave the researcher permission to 
utilize these scales in this translational research study. 
Morisky’s Medication Adherence Scale 
Medication adherence was measured pre and post intervention to answer the clinical 
question of whether HBPM in patients with hypertension increase adherence to blood pressure 
monitoring and medication compliance. Krousel-Wood et al. (2009), Morisky, Ang, Krousel-
Wood, and Ward (2008), and Morisky and DiMatteo (2011) established Morisky’s Medication 
Adherence Scale (MMAS-8), which is an eight-item scale to assess medication adherence in 
patients with various chronic diseases including hypertension (Appendix C). The scale utilizes a 
“yes” and “no” response for items 1-7 and for item 8 a five-point Likert scale is utilized 
measuring from “never/rarely” to  “all the time” (Krousel-Wood et al., 2009; Morisky et al., 
2008; Morisky & DiMatteo, 2011). Some of the items are reverse coded with a total scale range 
from 0 to 8, with 8 equivocating to high adherence, 6 to 8 medium adherence, and less than 6 
low adherence (Krousel-Wood et al., 2009; Morisky et al., 2008; Morisky & DiMatteo, 2011). 





The MMAS-8 has shown to be valid and reliable according to Pérez-Escamilla, Franco-Trigo, 
Moullin, Martínez-Martínez, and García-Corpas (2015). The Pérez-Escamilla et al. (2015) 
literature review compared several medication adherence instruments, but Morisky’s had the 
highest validity and reliability with a Crohnbach’s alpha of 0.83. Appendix D displays the 
questionnaire developed by Krousel-Wood et al. (2009), Morisky et al. (2008), and Morisky and 
DiMatteo (2011), which is copyrighted. The authors gave the researcher permission with a 
written agreement to utilize this scale for this translational research study. 
Protection of Human Subjects 
Informed consent was obtained prior to the initiation of the translational research project 
(Appendix F). The information and consent forms were provided to the prospective participants. 
The participants signed and submitted consent forms to the clinic manager and were returned to 
the PI. Each participant was provided a copy of the informed consent for his or her records. 
Information security and patient information protection is important in the process of this 
translational project. To ensure data is protected in accordance to the Health Insurance 
Portability and Accountability Act (HIPAA) privacy rule and the Georgia College & State 
University’s Institutional Review Board (GCSU IRB) by which this project was approved, the 
researcher did the following:  
1. The clinician established an ID number for each participant. The ID number and code-list 
will be kept separately on paper and via an electronic file.  
2. All paper work, code-list, signed consents, and written surveys will be kept in a locked 
file drawer in a locked and secure office. 





3. Any electronic files kept on the clinician’s computer will be password protected as well 
as the computer itself. Data files on the computer will be encrypted by Apple’s OS X 
folder encryption software. 
4. Any back-up files and data that will be saved on a portable drive will also be password 
protected. Again, data files on the computer will be encrypted by Apple’s OS X folder 
encryption software. 
5. Any lost or stolen information or property will be reported to GCSU’s IRB immediately 
and handled per the institution’s protocol.  
6. All patient data will be kept and securely stored for three years following the research 
study. After three years the data will be deleted and destroyed. 
There were no immediate risks associated with home-based blood pressure monitoring. 
However, being diagnosed and treated for hypertension comes with risks of psychological stress 
and physical damage to the heart and arteries. The researcher facilitated emotional and 
psychological support throughout the study of HBPM.  The introduction of the study began with 
HBPM education. The participants were encouraged to bring family or friends to the education 
for social support. The education provided the participants with an introductory knowledge basis 
to HBPM and an opportunity to become comfortable with home monitoring and also provides 
and opportunity of social support with other individuals with a similar diagnosis.  
The flagging system was a proactive measure to ensure patients were equipped with the 
materials necessary to monitor and evaluate their blood pressures on a daily basis. The flagging 
system was a reference tool with the necessary advisory instructions for the participant to 
reference every time the blood pressure was taken. The reference tool also provides supportive 
measures to help prompt the patient in critically analyzing reasons for changes in BP. Signs and 





symptoms that were discussed with participants that would require immediate medical attention 
included: chest discomfort, shortness of breath, facial drooping, sudden severe headache, arm 
weakness, speech difficulty, nausea/vomiting, lightheadedness, or dizziness. If any of these 
symptoms occurred, patients were instructed to call 911, immediately. One participant was 
discontinued from the study for safety measure. 
Data Analysis Plan 
Phase 3: Post Evaluation 
Descriptive and outcomes data was first cleaned and evaluated for missing data and 
outliers. Missing data was identified via exploratory analysis and outliers via scatterplots, 
boxplots and Z-scores. Descriptive statistics were used to describe the demographics of the 
sample. Descriptive statistics included frequencies for nominal and ordinal level measurements 
(gender, ethnicity, BMI, tobacco use, SEF, PMH, and PHU). For ratio level measurements (age, 
weight, height, QoBPM, HBPKS, HBPSCS, MMAS, SBP, and DBP) mean, median, mode, 
standard deviation, confidence intervals, kurtosis and skewness will be obtained to assess for 
normality and central tendency. Internal consistency reliability of both instruments were 
evaluated and discussed in the instruments section of this manuscript.  
Clinical Question 1. Patients receiving the HBPM program will have lower blood 
pressures at 60 days. SPSS Version 24 was used to conduct inferential statistics with the two-
tailed paired t-test. The two-tailed paired t-test is most operative in showing whether or not the 
HBPM program is effective since this is a pre-test and post-test quasi-experimental study. A two-
tailed paired t-test will provide enough power to show whether the HBPM program is or is not 
effective in the management of uncontrolled hypertension. The dependent variable, blood 
pressure, is a ratio level of measurement and if normal distribution is true, this variable fits the 





assumptions for parametric testing. Results were assessed at multiple time points (four weeks 
and eight weeks) to assess the progression of the study among the experimental group. Pre and 
post HBPM intervention blood pressure results were compared among the experimental and 
control groups. Analysis of Covariance (ANCOVA) testing was conducted to rule-out 
confounding variables, for example, the variables age, kidney disease, and African American 
men. 
Clinical Question 2. Patients receiving the HBPM program will have increased 
adherence to HBPM monitoring at 60 days. The number of missed data entries was tabulated for 
each participant to evaluate monitoring adherence. Of the 60 days (120 data entries) the project 
was implemented, each participant was allotted 12 missed data entries (10%). Greater than 12 
missed data entries over the course of the project was considered decreased adherence to the 
HBPM program. 
Clinical Question 3. Patients receiving the HBPM program will have increased 
adherence to hypertension lifestyle (low fat and salt diet, diet high in fruits and vegetables, daily 
30-min physical activity, minimal stress, healthy weight, minimal alcohol and tobacco use, 
doctor follow-up, and medication adherence) changes than those in the control at 60 days. Again, 
SPSS Version 24 was used to conduct inferential statistics with the two-tailed paired t-test. A 
pre-test and post-test of the knowledge scale and self-care scale was conducted to determine 
whether or not the HBPM education and monitoring process improved patient education and 
self-care skills. The dependent variables are the responses to the HBPKS and HBPSC surveys 
which are ratio levels of measurement and if normal distribution is true, this variable fits the 
assumptions for parametric testing. Pre and post survey responses will be compared among the 





experimental and control groups to evaluate the effectiveness in improving hypertension 
management adherence. 
Clinical Question 4. Patients receiving the HBPM program will have higher adherence 
to medication therapy than those in the control group at 60 days. Again, SPSS Version 24 was 
used to conduct inferential statistics with the two-tailed paired t-test. A pre-test and post-test 
medication adherence questionnaire was utilized to determine whether the HBPM program 
improved medication adherence. Again, SPSS Version 24 was used to conduct inferential 
statistics with the two-tailed paired t-test. The dependent variables are the responses to the 
MMAS-8 survey, which are ratio levels of measurement. If normal distribution is true, this 
variable fits the assumptions for parametric testing. Pre and post survey responses will be 
compared among the experimental and control groups to evaluate the effectiveness in improving 
hypertensive medication adherence. 
Feasibility 
 Timeline 
 The timeframe was eight-weeks to successfully implement the translational care project. 
The staff was educated on the HBPM process involving proper body mechanics and 
hypertension management prior to the beginning of the study in person and via web-ex on July 
26th. Due to time constraints, participant recruitment and project implementation occurred 
simultaneously in small groups. As the provider referred participants, classes were assigned 
based on the number labeled in their education and informed consent packer. The even numbered 
participants were a part of the experimental group and the odd numbered participants were a part 
of the control group. Educational courses were scheduled weekly on Tuesday’s from 5-7pm and 
Thursday’s from 4-5:30pm for three months (August 2nd to October 11th). At the beginning of 





each seminar a pre-test Blood Pressure Knowledge Scale, Self-care Scale was completed and 
MMAS-8 was conducted. HBPM began the day after education, where blood pressures were to 
be taken twice daily, 12-hours a part. Each participants start date was recorded and tracked to 
ensure prompt follow-up. The results were examined on a monthly basis by the researcher and 
forwarded to the participants’ care provider. After eight-weeks of HBPM implementation, post-
test Blood Pressure Knowledge Scale, Self-care Scale, and MMAS-8 was conducted in person, 
via phone or email and data analysis began.  
Budget  
 The researcher developed a Go Fund Me account 
(https://www.gofundme.com/HBPM2016) and collected $1,920 to purchase blood pressure 
monitors for the participants. The researcher also received two scholarships through Georgia 
College and State University from the Carolyn M. Maynard Nursing Scholarship fund and the 
Marjorie G. Prentice Graduate Research Scholarship fund for a total of $893. Funding helped 
provide blood pressure monitors to patients and cover costs related to educational materials. The 
total cost of the blood pressure monitors was $3041.48 for the entire sample population after a 
discount provided by Omron Healthcare.  
Benefit  
 Home-based blood pressure monitoring is innovative technology that will help health 
care providers deliver individualized patient care based on accurately reported blood pressure 
results. This project is the beginning of future large scaled projects. A HBPM program can be 
costly and therefore proper implementation is essential. Yet, compared to the billions of dollars 
spent on hypertension, treatment, and co-morbid conditions; improved blood pressure control 
will decrease the prevalence of co-morbid conditions and decrease health care costs. The HBPM 





program decreases patient expenditures due to decreased in-office visits and co-pays and 
decreased transportation needs or time off work. HBPM also has the potential to increase 
revenue to the health care practice for virtual visits. Often patients are lost to follow-up due to 
conflicting schedules and transportation (Young et al., 2015). HBPM with telecommunication 
management provides an avenue for more timely, effective, and individualized patient care. 
According to the CDC (2014), Medicare Part B, Medicare Part C, Medicaid, and private 
insurance provide coverage for Ambulatory Blood Pressure Monitoring for diagnostic accuracy 
of hypertension, whereas, in most insurance plans, HBPM coverage is limited. With an increase 
in successful studies, such as the one proposed, legislation could be initiated to increase coverage 
and reimbursement cost of HBPM programs. 





Chapter IV:  
Results 
 The results of this pre-test and post-test clinical trial of HBPM are discussed in this 
chapter. Findings reported here include descriptive statistics concerning the sample of 
participants and data addressing the research questions. Data screening was performed prior to 
conducting the statistical analyses in SPSS Version 24. Data was verified utilizing a double entry 
method where two separate databases were created and compared to identify discrepancies. 
Inconsistencies were then reconciled with the participants’ original data and a substitution method 
was utilized for missing data. 
 Examination of all continuous variables was conducted to determine normal distribution 
using descriptive statistics for central tendency, Fisher’s exact for skewness and kurtosis, histogram, 
Q-Q normality plots, Kolmogorov-Smirov test, and Shapiro-Wilk test. Each variable either exhibited 
normality or near normal distribution and therefore parametric testing was utilized to evaluate the 
results. The student t-test and Chi-square (X2) test were conducted to determine whether a covariate 
existed among the variables of age, gender, ethnicity, and past medical history of chronic kidney 
disease. The results were insignificant for all potential covariates and therefore no covariates were 
controlled for in hypothesis testing.  
Sample Characteristics 
 A total of 20 adults participated in the HBPM program. While initially the inclusion 
criteria for the study limited the participant age range to 18-60 years old, in the interest of the 
protection of human subjects and the ethical principle of justice, all ages were accepted into the 
study. Data was collected and analyzed for the entire sample since the purpose of the HBPM 
program was to demonstrate an improvement in blood pressure and adherence to the program, 
not to achieve a specific threshold as designated by the JNC VIII guidelines. Those meeting the 





inclusion criteria were randomized into the experimental (n=11) and control group (n=9) as 
demonstrated in Figure 4, the CONSORT Flow Diagram (Altman et al., 2001). The flow diagram 
outlines the flow of participants throughout the project revealing the forfeiture of two 
participants both due to lost to follow up. One participant did not submit results and researcher 
was unable to reach participant and the other discontinued due to hospitalization for hypertensive 
emergency. Data analysis was completed on all 20 participants. For the two participants whom 
did not complete the study, post-intervention data entries were substituted using their pre-
intervention results.  
  








Figure 4: CONSORT Flow Diagram (Altman et al., 2001).  
*Participants were lost to follow-up at 30 days. All participants’ pre-intervention data was analyzed; the two participants lost to follow-up had 
missing data for the 60-day data analysis. 
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Analysed  (n= 11) 
• Excluded from analysis (n= 0) 
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• Did not submit results and unable to reach 
participant. 
• Hospitalized for hypertensive emergency. 
Allocated to Intervention group (n= 11) 
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Analysed  (n=9) 





Randomized (n= 20) 
Enrollment 





 The participant’s demographics, medical history, lifestyle, and socio-economic status are 
described in detail in Table 1. The study participants were primarily male (55%), Caucasian 
(45%), or African American (40%). Two participants were Hispanic (10%) and one “Other” 
(5%). Participants’ ages ranged from 35 to 82 with a mean age of 58.05 (SD = 12.88). Regarding 
lifestyle, a majority of the sample was considered overweight (50%) with a BMI of 25 to 29.9 (M 
= 31.0) and weight ranging from 141lbs to 270lbs; only one participant was a normal BMI (5%). 
A large percentage of participants did not use tobacco products (75%). Concerning pre-existing 
conditions that could cause hypertension, participants were positive for a history of Type 2 
Diabetes Mellitus (75%), hyperlipidemia (50%), CKD (55%) and sleep apnea (20%). 
Participants on average had 2.8 (SD = 1.9) blood pressure medications prescribed. 
Regarding the sample’s socio-economic status, a majority were high school graduates/GED 
equivalent (30%) or had a Bachelor’s degree (25%), married (50%), employed (40%) or retired 
(40%), uninsured (35%) or under a federally funded insurance program like Medicare (35%) 
with a mean household income of $34363.20 (SD = 25033.40). Overall, prior to the initiation of 
this research project, sixty percent of the sample had been performing some type of blood 
pressure monitoring at home.  
 





Table 1  
 
Descriptive Statistics of Sample Characteristics (n=20) 
 
  Participants 
Characteristics, n  Total Group (n = 20) 
Experimental 
Group 
(n = 11) 
Control 
Group 
(n = 9) 
Gender, n (%)    
Male 11 (55) 5 (45.5) 6 (66.7) 
Female 9 (45) 6 (54.5) 3 (33.3) 
Age M, (SD) 58.1 (12.9) 50.5 (9.3) 67.3 (10.44) 
Ethnicity, n (%)    
Caucasian 9 (45%) 3 (27.3) 6 (66.7) 
Hispanic/Latino 2 (10%) 2 (18.2) 0 (0) 
African American 8 (40) 5 (45.5) 3 (33.3) 
Native American 0 (0) 0 (0) 0 (0) 
Asian 0 (0) 0 (0) 0 (0) 
Other 1 (10) 1 (9.1) 0 (0) 
Educational Level, n (%)    
Some High School (no degree) 1 (5) 1 (9.1) 0 (0) 
High School Graduate/GED 6 (30) 5 (45.5) 1 (11.1) 
Some College (no degree) 4 (20) 1 (9.1) 3 (33.3) 
Trade School 2 (10) 2 (18.2) 0 (0) 
Bachelor’s 5 (25) 0 (0) 5 (55.6) 
Master’s 1 (5) 1 (9.1) 0 (0) 
Doctoral 1 (5) 1 (9.1) 0 (0) 
Marital Status, n (%)     
Single 2 (10) 2 (18.2) 0 (0) 
Married 10 (50) 4 (36.4) 6 (66.7) 
Widowed 2 (10) 0 (0) 2 (22.2) 
Divorced 4 (20) 3 (27.3) 1 (11.1) 
Separated 2 (10) 2 (18.2) 0 (0) 
Employment Status, n (%)     
Employed for Wages 8 (40) 7 (63.6) 1 (11.1) 
Self-Employed 1 (5) 0 (0) 1 (11.1) 
Unemployed 1 (5) 1 (9.1) 0 (0) 
Homemaker 1 (5) 1 (9.1) 0 (0) 
Retired 8 (40) 1 (9.1) 7 (77.8) 
Disabled 1 (5) 1 (9.1) 0 (0) 





Health Insurance Status, n (%)    
Uninsured 7 (35) 6 (54.5) 1 (11.1) 





(Table 1 continued)    
    
Employment-Based Plan 3 (15) 3 (27.3) 0 (0) 
Direct-Purchase Private Plan 2 (10) 1 (9.1) 1 (11.1) 
Medicare 7 (35) 0 (0) 7 (77.8) 
Medicaid 1 (5) 1 (9.1) 0 (0) 
Quantity of BP Meds Prescribed, M (SD) 2.8 (1.9) 1.9 (1.4) 3.9 (1.97) 
Currently Monitoring HBPM, n (%)    
Yes 13 (65) 6 (54.5) 7 (77.8) 
No 7 (35) 5 (45.5) 2 (22.2) 
Past Medical History, n (%)    
Diabetes Type 1 0 (0) 0 (0) 0 (0) 
Diabetes Type 2 15 (75) 7 (63.6) 8 (88.9) 
Hyperlipidemia 10 (50) 3 (27.3) 7 (77.8) 
Chronic Kidney Disease 11 (55) 4 (36.4) 7 (77.8) 
Sleep Apnea 5 (25) 0 (0) 5 (55.6) 
Tobacco Use, n (%)    
Yes 5 (25) 3 (27.3) 2 (22.2) 
No 15 (75) 8 (72.7) 7 (77.8) 
BMI, M (SD) 31.0 (5.4) 31.6 (6.7) 30.4 (3.4) 
Blood Pressure (BP), M (SD)    
Baseline-Systolic BP 158.9 (12.8) 154.5 (8.7) 164.2 (15.2) 
Baseline-Diastolic BP 90.2 (13.1) 93.7 (7.2) 85.8 (17.3) 
Post-Systolic BP 142.9 (19.1) 145.8 (19.3) 139.2 (19.2) 
Post-Diastolic BP 81.6 (12.5) 87.8 (7.9) 74 (13.2) 
Knowledge Scale (KS), M (SD) 
   Baseline-KS 67.7 (9.8) 69.6 (9.8) 65.4 (9.8) 
Post-KS 67 (8.1) 66.5 (8.7) 67.7 (7.7) 
Self-Care Scale (SCS), M (SCS) 
   Baseline-SCS 46.3 (11.5) 48.0 (13.3) 44.3 (9.1) 
Post-SCS 51.0 (8.6) 50.6 (9.7) 51.3 (7.7) 
MMAS, M (SD)    
Baseline-MMAS 5.7 (1.9) 5.88 (1.83) 5.4 (2.0) 
Post-MMAS 5.9 (1.6) 5.86 (1.64) 5.9 (1.7) 
Note. n = Total participants, % = percentage, M = Mean, SD = Standard deviation, meds = medications,  
MMAS = Morisky’s Medication Adherence Scale. 
  





Clinical Question 1 
 An independent samples t-test was used to test the hypothesis that patients receiving the 
HBPM program will significantly lower blood pressure at 60 days than those in the control 
group.  This hypothesis was not supported. Patients receiving the HBPM program had higher 
systolic blood pressures (M = 145.8, SD = 19.3) than those in the control group [(M = 139.2, SD 
= 19.2), t(18) = -.76, p = .456] at 60 days. Similarly, patients receiving the HBPM program had 
significantly higher diastolic blood pressures (M = 87.8, SD = 7.94) than those in the control 
group [(M = 74.0, SD =13.2), t (18) = -2.9, p = .010] at the 60-day blood pressure re-evaluation. 
Clinical Question 2  
 An adherence scale was developed to determine whether patients receiving the HBPM 
program had increased adherence to HBPM monitoring. For each day the participant checked 
their blood pressure two points were accumulated, with a total possible score ranging from 0-
120. Adherence was split into three categories, Low 0-40 (15%), Moderate 41-80 (15%), and 
High Adherence >81 (45%). An independent sample t-test was used to determine whether 
patients receiving the HBPM program had higher adherence to blood pressure monitoring at 60 
days. This hypothesis was supported. Patients receiving the HBPM program had higher HBPM 
adherence scores (M = 70.1, SD = 43.74) than the control group [(M = 46.0, SD = 52.8), t (18) = 
-1.117, p = .279] at 60 days. 
Clinical Question 3 
 An independent sample t-test was used to determine whether patients receiving the 
HBPM program had higher adherence to hypertension lifestyle (low fat and salt diet, diet high in 
fruits and vegetables, daily 30-min physical activity, minimal stress, healthy weight, minimal 
alcohol and tobacco use, doctor follow-up, and medication adherence) changes at 60 days. This 





hypothesis was not supported. Patients receiving the HBPM program had lower self-care survey 
scores (M = 50.6, SD = 9.74) than the control group [(M = 51.33, SD = 7.66), t (18) = .175, p = 
.863] at 60 days. Similarly, patients receiving the HBPM program had lower knowledge scale 
survey scores (M = 66.45, SD = 8.7) than the control group [(M = 67.67, SD = 7.7), t (18) = .326, 
p = .748] at the end of 60 days. 
Clinical Question 4 
 An independent samples t-test was used to determine whether patients receiving the 
HBPM program had higher adherence to medication therapy than those in the control group at 60 
days. This hypothesis was not supported. Patients receiving the HBPM program had lower 
medication adherence survey scores (M = 5.86, SD = 1.73) than those in the control group [(M = 
5.88, SD = 1.64), t (18) = .033, p = .974] at 60 days. 
Summary 
 An analysis of a sample of 20 hypertensive patients enrolled in a structured HBPM 
program was completed. For clinical question 1, inferential statistics demonstrate a statistically 
insignificant increase in systolic blood pressure, but a statistically significant increase in diastolic 
blood pressure between the experimental and control groups at 60 days. There was no statistical 
significance in the improvement of HBPM adherence, knowledge, self-care, or medication 
adherence in clinical questions 2, 3, and 4 between the two groups at 60 days.  
  







 The rising prevalence and mortality rate of hypertension makes this an important health 
care issue to address (CDC, 2015). To help address the CDC’s (2015) initiatives to prevent, treat 
and control hypertension, it is necessary to identify strategies like HBPM to improve blood 
pressure monitoring in the treatment of hypertensive patients. Based on the data analysis, a 
statistically significant improvement in blood pressure management, monitoring adherence, 
knowledge, self-care, and medication adherence was not achieved in the implementation of 
HBPM compared to hypertensive patients who did not receive the intervention. However, while 
enhanced monitoring adherence was demonstrated among the experimental group, it was not 
statistically significant. 
 While the findings suggest there is no statistical support for the use of HBPM in practice, 
the translational research project is relevant in that it establishes a guide to implementing HBPM 
into practice and addressing hypertension management.  The results are not relative to similar 
studies in that the study was underpowered and should be re-examined with a larger sample size. 
In comparison to similar HBPM studies with an adequate sample size, a statistically significant 
average decrease of 30.5 mmHg (p=0.002) in systolic blood pressure occurred in one study 
(McManus et al., 2010) and a 12-point reduction in systolic blood pressure was demonstrated at 
12 months in another study (McManus et al., 2014). Crabtree & Stuart-Shor (2014) demonstrated 
a 60% improvement in a 12-month study of HBPM. Differences between these studies and the 
current study are the implementation timeframe and sample size, demonstrating a few of the 
constraints of this study. 






 There were several limitations of this study to be discussed. The first obstacle was limited 
funding for the purchase of blood pressure monitors. A-priori power analysis was conducted for 
a two-tailed t-test indicated that 128 participants were desired to achieve statistical significance. 
The initial goal for the study was to have one large cohort of participants to obtain the power 
analysis. However, funding was required to purchase the amount of blood pressure monitors 
needed to fulfill the study a-priori sample size. Therefore, the researcher sought grants, investors, 
and scholarship funding for the purchase of the monitors for 128 participants. The short length of 
time from the planning phase to implementation of the project made it difficult to sequester the 
amount of funding necessary to purchase the blood pressure monitors. Many grants that were 
inquired about required at least a one-year timeframe before funds were distributed. Therefore, a 
Go Fund Me was established for the procurement of funding, which required additional time for 
growth. Once the allotted donations and scholarships were obtained a budget was created. The 
study sample size, a-priori, was reevaluated to preclude developing a control group whom would 
not receive a blood pressure monitor. The time required to obtain the funding necessary to 
implement the project delayed the time available for the implementation phase of this 
translational research project and therefore was shortened to 60 days.  
 Recruitment of participants for this study was difficult due to practice accessibility. 
Initially, the researcher contacted several primary practices to implement the study. While there 
was great interest in the study, it was difficult to find stakeholders in the research project. 
Specifically, one particular practice declined to participate due to being in between medical 
directors and not being able to facilitate the study during the timeframe required.  Eventually, 
two sites confirmed interest and provided site approval for the HBPM project. Unfortunately, 





one site cancelled their participation just prior to the implementation of the project due to 
changes in practice dynamics. Therefore, implementation went forward with one practice site 
approval, making participant recruitment limited. Approximately four weeks in the 
implementation process a second practice site was added to recruit additional participants 
however time for recruitment, project implementation, and data analysis was limited for this 
practice group. 
 In addition to a small sample size, this is a convenience sample, which has the potential 
to introduce bias, which decreased the statistical significance of the study. While the participants 
were randomly assigned to the control and experimental groups, they were recruited from two 
practice sites that cannot represent the population of hypertensive patients. Convenience samples 
tend to misrepresent the population as a whole and are not ideal in the research process. A 
complete randomized control study with an adequate sample size over a longer period of time 
would strengthen the study design and more likely provide results similar to studies identified in 
the literature review. 
Strengths 
 While the sample size was inadequate to provide statistical significance of the pre-test 
and post-test effectiveness of HBPM, it is a potential pilot for future studies. On a small scale, 
the study conducted helps evaluate practicability, time, cost-effectiveness, complications, and 
effect size to implement and sustain successful large-scale study designs in the future. Therefore, 
the potential funding sources for the purchase of blood pressure devices identified in this 
translational research project would benefit future research opportunities. Also, the methodology 
of this project provides the phases necessary to incorporate a well-structured HBPM program 
into practice. For instance, the resources and references identified in this translational research 





project can be utilized to construct a hypertension educational program for patients and staff 
whom are key stakeholders in the success of similar research studies. 
Future Research  
 Future research is necessary to analyze the effectiveness of a HBPM program. Future 
studies can incorporate the existing HBPM program, model and tools to examine blood pressure 
results among a larger sample over a longer period of time. Recruiting participants from larger or 
multiple institutions could expound the sample size. Utilizing multiple facilities allows the 
experimental and control groups to then be randomized on a per facility basis. For studies with 
larger sample sizes, more researchers would be necessary to properly distribute the workload. A 
larger sample size would improve statistical significance and improve generalizability of results. 
In addition to a larger sample, other studies that demonstrated significant improvement in blood 
pressure monitored results for 6 to 12 months. A longer study period would allow for the 
collection of more data for a more accurate data analysis. 
 The models and tools utilized in this study can be easily replicated to evaluate various 
settings and cultures. The translating evidence into research model by Pronovost, Berenholtz, 
and Needham (2008) is a simple model that can be utilized in translating knowledge into practice 
regardless of setting or culture. Whereas, the Hill-Levine’s Conceptual Model for Hypertension 
Management Adherence was a conceptual model formulated to improve hypertension 
management strategies among African American women (Hill et al., 1999). For the purposes of 
this study, this model was utilized to structure a proper educational program, however, future 
studies would benefit form utilizing this model to analyze HBPM adherence among African 
Americans.  





 In relationship to adherence, it appears that HBPM improved monitoring adherence. 
While the experimental group had higher blood pressure results (with a significantly higher 
diastolic blood pressure) than the control group, this could be due to the small sample size or 
possibly due to stressors implicated by having to evaluate blood pressures in the home. Future 
studies should be challenged to perform qualitative studies to explore patient perceptions of the 
program. As advances in telemonitoring continue to make large strides, analysis of self-
monitoring and self-care in hypertension management should be assessed to ensure patients are 
receiving quality care and meeting their own health care expectations. 
 Blood pressure monitors for HBPM can be quite expensive, especially for validated 
monitors that provide the integration of mobile applications for transmitting data. With a 
majority of health disparities occurring in underserved areas, future studies should examine the 
cost effectiveness of HBPM and determine methods in which to increase affordability. Since 
HBPM provides improved individualized care without the expenditure of excessive resources, 
governmental agencies should be challenged to increase coverage and reimbursement cost of 
HBPM programs. 
Sustainability Analysis  
 Training of the staff on the implementation of the home-based blood pressure monitoring 
program was instrumental in sustaining the life of this project. Incorporating the staff in the 
patient education of HBPM and providers in the supervision of the program provides a 
foreground for the stability and future of HBPM in the practices. The program also utilizes 
protocols and algorithms from national organizations such as the American Heart Association 
(AHA) and Center’s of Disease Prevention and Control (CDC) that will allow for continued 





access to reference tools and updates. The researcher will remain available for further assessment 
and revamping of the program as needed.     
Implications for Nursing Practice 
 With rising difficulties in the access to affordable health care, telemonitoring is essential 
to the improvement of patient outcomes. HBPM is an innovative intervention that helps 
providers administer individualized patient care based on accurately reported blood pressure 
results without frequent in-office follow-ups. Successful HBPM implementation requires social 
support and the translational research project demonstrates the importance of conducting home 
monitoring in a supportive environment. Therefore, properly trained nursing staff by doctoral 
prepared nurse clinicians is instrumental in ensuring patients and staff members are receiving the 
proper education, instruction and tools necessary to successfully implement HBPM. The 
translational research project implicates a feasible systematic approach to developing a 
successful nurse-led HBPM program into practice.  
 Nurses, researchers, and translational research clinicians play an integral part in the 
education, prevention, and management of chronic diseases. Nurses are at the forefront in the 
clinical setting and represent the individuals actively implementing evidence-based practice 
guidelines. In regards to HBPM, they are responsible for accurately obtaining blood pressures 
and being able to demonstrate proper HBPM techniques, as well as, acknowledging processes 
that are ineffective in the clinical setting. Doctor of nursing practice (DNP) researchers 
disseminate research into practice and are capable of identifying robust evidence-based research 
to effectively change policy and procedures. DNP researchers may conduct a literature review to 
identify improved methods of blood pressure monitoring or implementation practices. 





Collaboration efforts between PhD and DNP prepared nurses is essential in the development and 
implementation of new HBPM practices. 
Conclusion 
 The purpose of the translational research project was to determine the effectiveness of 
home-based blood pressure monitoring in the management of pre-hypertension, newly 
diagnosed, or uncontrolled hypertension. Based on the data analysis, a statistically significant 
improvement in hypertension management was not achieved in the implementation of a HBPM 
program. While there is limited statistical support for this translational research project, other 
resources support HBPM as an innovative program that has the potential to provide healthcare 
providers an avenue for more timely, effective, and individualized patient care. Literature 
demonstrates that improved blood pressure control has the potential to decrease the prevalence of 
co-morbid conditions and decrease health care costs. With an increase in successful studies 
legislation could be challenged to increase coverage and reimbursement cost for blood pressure 
monitors and more HBPM programs in practice. Continued research related to HBPM and 
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Investigator: Nicole Bello  ID #:  
   Date:  
Carefully read each question answer most appropriately. 
1. What is your gender? 
A. Male 
B. Female 
2. What is your age?_________ 
3. Please specify your ethnicity: 
A. White 
B. Hispanic/Latino 
C. Black/African American 
D. Native American/American Indian 
E. Asian/Pacific Islander 
F. Other 
4. Weight ___________ 
5. Height ____________ 
6. Use of Tobacco products? Yes/No 





7. How many blood pressure medications do you take? ___________ 
8. Do you currently monitor your blood pressure at home? Yes/No 
9.  What is the highest degree or level of school you have completed? If currently enrolled, 
highest degree received. 
A. Some high school, no diploma 
B. High school graduate, diploma or the equivalent (GED) 
C. Some college, no degree 
D. Trade/Technical school 
E. Associates degree 
F. Bachelor’s degree 
G. Master’s degree 
H. Professional degree 
I. Doctoral degree 
10.  What is your marital status? 
A. Single, never married 
B. Married/domestic partnership 
C. Widowed 
D. Divorced  
E. Separated 
11.  What is your occupation? 
A. Employed for wages 
B. Self-employed 
C. Unemployed and looking for work 
D. Unemployed and not currently looking for work 





E. A homemaker 
F. A student 
G. Military 
H. Retired 
I. Disabled  
12.  What is your total household income?______________ 
13. What is your health insurance status? 
A. Uninsured 
B. Employment-based private plan 
C. Direct-purchase private plan 
D. Medicare 
E. Medicaid 
F. Military health plan 
14. Have you ever been diagnosed with_____? (Select all that apply). 
A. Diabetes Mellitus Type I  
B. Diabetes Mellitus Type II 
C. High Cholesterol 
D. Sleep Apnea 
E. Chronic Kidney Disease 
  







ID NO. ___________________ 
 
 
Blood Pressure Knowledge Scale© (revised) 
 
In general, how likely do you believe that the following statements are true? Using the scale below, please 
choose the number that best matches your answer.  
 
 




Eating a low fat diet each day will help me 
keep my blood pressure within normal 
limits 
1 2 3 4 5 6 7 
2 Eating a low salt diet will help me keep my blood pressure within normal limits 1 2 3 4 5 6 7 
3 
Eating a diet with at least five fruits and 
vegetables each day will help me keep my 
blood pressure within normal limits 
1 2 3 4 5 6 7 
4 
Physical activity for at least 30 minutes 
each day will help me keep my blood 
pressure within normal limits 
1 2 3 4 5 6 7 
5 
Seeing my doctor on a regular basis will 
help me keep my blood pressure within 
normal limits 
1 2 3 4 5 6 7 
6 
If someone has high blood pressure the best 
way to keep their blood pressure within 
normal limits is by taking medicines every 
day as prescribed by their doctor 
1 2 3 4 5 6 7 
7 
Avoiding alcohol (such as beer, wine, 
liquor) will help me keep my blood 
pressure within normal limits 
1 2 3 4 5 6 7 
8 Reducing stress will help me keep my blood pressure within normal limits 1 2 3 4 5 6 7 
9 
Maintaining normal body weight would 
help me keep my blood pressure within 
normal limits 
1 2 3 4 5 6 7 
10 
Avoiding tobacco (such as smoking or 
chewing) would help me keep my blood 
pressure within normal limits 
1 2 3 4 5 6 7 
11 I will know if my blood pressure is high (above normal limits) because of how I feel 1 2 3 4 5 6 7 
© R.M. Peters 





Appendix C  
 




Blood Pressure Self-Care Scale© (revised) 
 
In general, how often are the following statements true about you? Using the scale below, please choose 




© R.M. Peters 
 













1 I am eating a low-fat diet each day  1 2 3 4 5 6 7 
2 I am eating a low-salt diet each day  1 2 3 4 5 6 7 
3 I am eating a diet with at least five fruits and vegetables each day  1 2 3 4 5 6 7 
4 I am physically active at least 30 minutes each day  1 2 3 4 5 6 7 
5 I am able to maintain a low level of stress each day  1 2 3 4 5 6 7 
6 I am able to maintain a healthy weight  1 2 3 4 5 6 7 
7 I am drinking two or more alcoholic drinks each day     1 2 3 4 5 6 7 
8 I use tobacco      1 2 3 4 5 6 7 
9 
I see my doctor as often as he/she tells 
me to.  1 2 3 4 5 6 7 
10 
I am taking my blood pressure pills 
exactly as prescribed by my doctor 
each day 
N/A 1 2 3 4 5 6 7 









Morisky DE, Ang A, Krousel-Wood M, Ward H. Predictive Validity of a Medication Adherence Measure 
for Hypertension Control. Journal of Clinical Hypertension 2008; 10(5):348-354 
Krousel-Wood MA, Islam T, Webber LS, Re RS, Morisky DE, Muntner P. New Medication Adherence 
Scale Versus Pharmacy Fill Rates in Seniors With Hypertension. Am J Manag Care 2009;15(1):59-
66. 
Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: Final 
response. J Clin Epidemio 2011; 64:258-263. PMID:21144706 
HYPERTENSION MANAGEMENT WITH HBPM 
  
  
 
67 
 
 
